-
Product Insights
NewRoche Diagnostics Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Roche Diagnostics Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Roche Diagnostics (Roche), a subsidiary of Roche Diagnostics International Ltd. is a diagnostic solution provider that offers pharmaceutical and diagnostic solutions. The company's products include blood glucose monitor, coagulation monitor, point-of-care systems, lancing systems and screening systems. Roche Diagnostics offers instrumentation, kits and support for nucleic acid test donor screening for HIV, hepatitis and west nile virus. The company offers...
-
Product Insights
NewRoche Diagnostics GmbH Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Roche Diagnostics GmbH Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Roche Diagnostics GmbH (Roche Diagnostics), a subsidiary of F. Hoffmann-La Roche Ltd, is a pharmaceutical company that offers diagnostic services. The company offers solutions in diagnostic segments and indications such as coagulation diagnostics, molecular diagnostics, tissue diagnostics, blood gas analysis, clinical chemistry, pre and post analysis, IT solution, research, immunochemistry, point of care diagnostics, and urinalysis. Its products comprise...
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Giredestrant
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Giredestrant report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Ipatasertib
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Ipatasertib report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Fenebrutinib
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Fenebrutinib report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Inavolisib
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Inavolisib report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Vanglusagene ensiparvovec
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Vanglusagene ensiparvovec report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Dirloctocogene Samoparvovec
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Dirloctocogene Samoparvovec report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Sefaxersen sodium
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Sefaxersen sodium report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewRoche Diagnostics International Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Roche Diagnostics International Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Roche Diagnostics International Ltd (Roche Diagnostics), a subsidiary of F. Hoffmann-La Roche Ltd, is a provider of diagnostic system solutions to clinics, laboratories and doctors’ offices. The company develops, produces and services instruments and software systems used in in-vitro diagnostics and bioanalytical research. It also offers diagnostic analysis systems and workflow solutions, and molecular diagnostic reagents and test...